Key result
Higher TPO/GC ratio strongly predicts suboptimal aspirin response in T2DM with ~0.88 AUC.
Why the study?
Cardiovascular disease prevention with low-dose aspirin can be less effective in patients with faster recovery of platelet COX-1 activity during the 24-hour dosing interval.
Does reduced platelet GPIbα shedding and increased TPO/GC ratio predict accelerated COX-1 recovery and suboptimal aspirin response in high cardiovascular risk patients?
Observational (n=205)
No
Does reduced platelet GPIbα shedding and increased TPO/GC ratio predict accelerated COX-1 recovery and suboptimal aspirin response in high cardiovascular risk patients?
A higher circulating TPO/GC ratio identifies patients with accelerated COX-1 recovery who may benefit from more frequent (twice-daily) aspirin dosing.
Answers are grounded in this paper and cite their sources.
Higher TPO/GC ratio may flag suboptimal aspirin responders; leaves open whether dosing adjustments improve outcomes.
Cardiovascular (CV) disease prevention with low-dose aspirin can be less effective in patients with a faster recovery of platelet (PLT) cyclooxygenase (COX)-1 activity during the 24-hour dosing interval. We previously showed that incomplete suppression of TXA2 over 24 hours can be rescued by a twice daily aspirin regimen. Here we show that reduced PLT glycoprotein (GP)Ibα shedding characterizes patients with accelerated COX-1 recovery and may contribute to higher thrombopoietin (TPO) production and higher rates of newly formed PLT, escaping aspirin inhibition over 24 hours. Two hundred aspirin-treated patients with high CV risk (100 with type 2 diabetes mellitus) were stratified according to the kinetics of PLT COX-1 activity recovery during the 10- to 24-hour dosing interval. Whole proteome analysis showed that PLT from patients with accelerated COX-1 recovery were enriched in proteins involved in cell survival, inhibition of apoptosis and cellular protrusion formation. In agreement, we documented increased plasma TPO, megakaryocyte maturation and proplatelet formation, and conversely increased PLT galactose and reduced caspase 3, phosphatidylserine exposure and ADAM17 activation, translating into diminished GPIbα cleavage and glycocalicin (GC) release. Treatment of HepG2 cells with recombinant GC led to a dose-dependent reduction of TPO mRNA in the liver, suggesting that reduced GPIbα ectodomain shedding may unleash thrombopoiesis. A cluster of clinical markers, including younger age, non-alcoholic fatty liver disease, visceral obesity and higher TPO/GC ratio, predicted with significant accuracy the likelihood of faster COX-1 recovery and suboptimal aspirin response. Circulating TPO/GC ratio, reflecting a dysregulation of PLT lifespan and production, may provide a simple tool to identify patients amenable to more frequent aspirin daily dosing.
No takes yet. Share an insight, caveat, or question.
Simeone et al. (2022) conducted an observational in High cardiovascular risk with or without type 2 diabetes mellitus (n=205). Aspirin vs. Good aspirin responders (1st tertile of sTXB2 recovery slope) was evaluated on Prediction of poor aspirin response (third sTXB2 slope tertile) in T2DM patients using a model including TPO/GC ratio (AUC 0.883, 95% CI 0.799-0.966). A higher circulating thrombopoietin-to-glycocalicin ratio, reflecting dysregulated platelet lifespan and production, strongly predicted suboptimal aspirin response with high diagnostic accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: